• Front Research
  • Posts
  • Carasent (CARA): Poised for Stronger Growth with Increased Sales Volumes and Controlled Costs

Carasent (CARA): Poised for Stronger Growth with Increased Sales Volumes and Controlled Costs

Ticker: CARA | Price: 11 NOK | Price target: 26 NOK | Timeframe: 12 months | Source: Redeye πŸ’» Technology/Software Industry | πŸš€ Growth Poised | πŸ“ˆ Bullish idea

❝

Disclaimer - Not Investment Advice

The content on Front Research is for informational purposes only and should not be considered as investment advice financial advice. One should always consult a qualified professional before making any investment decisions. Investments carry risks, including the potential loss of capital. Front Research and its authors bear no liability for decisions made based on the information provided here. All views are personal and not reflective of any company mentioned. Front Research, it’s affilaites, personnel, clients and/or partners might hold investments in securites discussed.

By accessing Front Research, you acknowledge and agree to this disclaimer.

STOCK IDEA - Carasent

Carasent (CARA): Poised for Stronger Growth with Increased Sales Volumes and Controlled Costs

Carasent, traded in Norway, is highlighted as a promising investment due to its strong growth prospects, driven by increased sales and controlled costs. The Q4 2023 report revealed a 13% year-on-year increase in Annual Recurring Revenue (ARR) to NOK239m, with a revenue backlog of NOK8m showcasing sales momentum. Despite slightly lower margins, the period marked a record in new sales. With optimistic management and planned product launches in 2024, Carasent is expected to reach a positive EBITDA-CAPEX margin by late 2024. The valuation remains at NOK 11-43, with a base case of NOK 26. Investors are cautioned about the potential impact of a German acquisition, not included in the current estimates. Carasent's appeal lies in its ability to enhance healthcare processes and scalability, underpinned by its significant customer base and potential for network effects and customer loyalty.

Ticker: CARA | Price: 11 NOK | Price target: 26 NOK | Timeframe: 12 months | Source: Redeye

πŸ’» Technology/Software Industry | πŸš€ Growth Poised | πŸ“ˆ Bullish idea

πŸ“ Analysis: Dig deeper into this stock idea: Financials, valuation, moat analysis, timing, and more…upgrade to Limited Partner for access, only $14 per month.

Subscribe to PRO to read the rest.

Become a paying subscriber of PRO to get access to this post and other subscriber-only content.

Already a paying subscriber? Sign In

A subscription gets you:
Remove sponsor ads
PRO news brief feeds for deeper information edge.

Join the conversation

or to participate.